NTS and Alzheimer disease: Notably, mRNA levels of ghrelin and expression of its G protein–coupled receptors (neurotensin receptors 1 and 2) are decreased, whereas levels of neurotensin tend to decrease in the temporal lobe of patients with AD (Gahete et al., 2010).